Results 61 to 70 of about 27,268 (276)

Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies. [PDF]

, 2014
Hypertension after treatment with vascular endothelial growth factor (VEGF) receptor inhibitors is associated with superior treatment outcomes for advanced cancer patients.
Bakris, GL, Cohen, EEW, Fleming, GF, House, LK, Karovic, S, Karrison, TG, Levine, MR, Maitland, ML, Ratain, MJ, Rudek, MA, Thomeas, V, Wen, Y, Wright, JJ, Wu, K   +13 more
core   +2 more sources

Use of Extracorporeal Therapies to Treat Severe Caffeine Poisoning

Hemodialysis International, EarlyView.
ABSTRACT Introduction Reflecting on recent reports suggesting the efficacy of extracorporeal blood purification, including hemodialysis, for severe caffeine poisoning, we conducted a retrospective 5‐year follow‐up study on acute caffeine poisoning in Japan particularly focusing on extracorporeal blood purification.
Saeko Kohara, Yoshito Kamijo, Michiko Takai, Ryoko Kyan, Eiju Hasegawa, Takuya Shimane   +5 more
wiley   +1 more source

Monthly triple-dose gadolinium administration: potential associations with leukopenia, hypophosphatemia, and bone marrow T1 hyperintensity

Journal of International Medical Research, 2022
Objective Monthly scanning with triple-dose gadopentetate dimeglumine has been shown to be associated with progressive increases in bone T1 hyperintensity, hypophosphatemia, and leukopenia.
Daniel Chen, Ivan Wolansky, Jaime Imitola, Carl Malchoff, Rong Wu, Suhayl Dhib-Jalbut, Ketan Bulsara, Leo Wolansky   +7 more
doaj   +1 more source

Targeted Alkaline Phosphatase Therapy Enhances Alveolar Bone Healing in X‐Linked Hypophosphatemia in Mice

Journal of Periodontal Research, EarlyView.
Effects of exogenous tissue‐nonspecific alkaline phosphatase (TNAP) were analyzed in the Hyp mouse model of X‐linked hypophosphatemia (XLH). Maxillary first molars were extracted from wild‐type (WT) and Hyp mice at 6 weeks, and collagen gel ± TNAP was placed in sockets. In one group of Hyp mice, submucosal injections of TNAP or saline were delivered at
Aonjittra Phanrungsuwan, Bella Donnelly, José Luis Millán, Brian L. Foster   +3 more
wiley   +1 more source

Gendered Experiences of Intravenous Iron Infusion Reactions: A Patient Perspective

Journal of Patient Experience
Hypophosphatemia following iron infusion is thought to be a relatively rare complication of intravenous iron infusion, though research is beginning to demonstrate that it occurs more often than previously assumed.
Roxanna Nasseri Pebdani PhD, CRC, SFHEA
doaj   +1 more source

Association between phosphate disturbances and mortality among critically ill patients with sepsis or septic shock

BMC Pharmacology and Toxicology, 2021
Objective The aim of this study is to examine the association of hypophosphatemia and hyperphosphatemia on the first day of ICU admission with mortality in septic critically ill patients. Methods In this retrospective cohort study, all adult patients who
Shmeylan A. Al Harbi, Hasan M. Al-Dorzi, Albatool M. Al Meshari, Hani Tamim, Sheryl Ann I. Abdukahil, Musharaf Sadat, Yaseen Arabi   +6 more
doaj   +1 more source

QTc Prolongation in Veterans With Heroin Dependence on Methadone Maintenance Treatment [PDF]

, 2015
Background: QTc prolongation and Torsade de Ppointes have been reported in patients on methadone maintenance. Objectives: In this study, QTc was compared before and after the veteran (n = 49) was on a stable dosage of methadone for 8.72 ± 4.50 years ...
Fernandez, Antony, Hassamal, Sameer, Pandurangi, Ananda, Rekabdarkolaee, Hossein Moradi   +3 more
core   +2 more sources

Iron deficiency in heart failure: Epidemiology, diagnostic criteria and treatment modalities

ESC Heart Failure, Volume 12, Issue 2, Page 723-726, April 2025.
Stephan von Haehling
wiley   +1 more source

Successful Treatment of Refractory IgA‐Mediated Autoimmune Hemolytic Anemia With Bortezomib

eJHaem, Volume 6, Issue 6, December 2025.
ABSTRACT Introduction IgA‐mediated autoimmune hemolytic anemia (AIHA) is a rare condition associated with severe hemolysis and limited therapeutic response. Bortezomib, a proteasome inhibitor, targets plasma cells responsible for autoantibody production.
Silvia Neri, Corien L. Eckhardt, Boukje M. Beuger, Folman Folman, Eva Rettenbacher, Hanke L. Matlung, Taco W. Kuijpers, Josephine M. I. Vos, Robin van Bruggen   +8 more
wiley   +1 more source

Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors

Pediatric Blood &Cancer, Volume 72, Issue 12, December 2025.
ABSTRACT Background Combining immune checkpoint inhibitors (ICI) with chemotherapy may improve treatment response in children with solid tumors. We sought to determine the feasibility of combining vincristine, irinotecan, and temozolomide with the ICI atezolizumab in children with relapsed or refractory solid tumors (VITAS;). Methods Patients ≥6 months
Matthew E. Campbell, Sonja Stutzman, Sharon Primeaux, Deseray Sida, Minjae Lee, Avanthi T. Shah, Arhanti Sadanand, Elizabeth Sokol, Natalie B. Collins, Brian Turpin, Shoba Navai, Katie Albert, Theodore W. Laetsch, Dinesh Rakheja, Kenneth S. Chen, David E. Gerber, Andrew Y. Koh   +16 more
wiley   +1 more source